BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders]. 1990

T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
Second Department of Internal Medicine, School of Medicine, Mie University.

Sixty-eight patients with severe infections associated with hematopoietic disorders were treated with imipenem/cilastatin sodium (IPM/CS) and the efficacy and safety of this drug were evaluated. 1. Fifty-nine patients were evaluable for the efficacy. Clinical efficacies were excellent in 10 patients, good in 24, fair in 11 and poor in 14, and the overall efficacy rate was 57.6%. 2. The clinical efficacy rates were 62% against septicemia and suspected septicemia, 40% against pneumonia and 100% against urinary tract infection (1 case). 3. The clinical efficacy rates when these patients were grouped according to numbers of neutrophils after treatment were: less than 100/mm3; 44.4%, 101-500/mm3; 58.3% and over 501/mm3; 60.5%. The efficacy rate was particularly excellent, 60.0%, for patients with neutrophil counts were less than 100/mm3 both before and after treatment. 4. Sixty-eight patients were evaluable for the safety. Side effects were observed in 5 patients and abnormal laboratory test values were observed in 5 patients.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical evaluation of imipenem/cilastatin sodium against severe infections complicated with hematological disorders and solid tumors].
December 1989, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical evaluation of imipenem/cilastatin sodium against severe infections complicating hematological disorders and solid tumors].
August 1991, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
May 1989, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical study of imipenem/cilastatin sodium in children with severe infections].
January 1990, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
August 1991, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
December 1991, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Evaluation of imipenem/cilastatin sodium in neonatal infections].
November 1988, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
February 1993, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
May 1991, The Japanese journal of antibiotics,
T Tsukada, and N Katayama, and S Kageyama, and M Nishikawa, and T Kobayashi, and K Deguchi, and S Shirakawa, and N Minami
[Clinical evaluation of imipenem/cilastatin sodium in children].
July 1986, The Japanese journal of antibiotics,
Copied contents to your clipboard!